Symposia: Aggressive Lymphomas: Cellular Therapies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Translational Research, Lymphomas, Non-Hodgkin lymphoma, Drug development, Clinical Research, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Real-world evidence, Aggressive lymphoma, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Translational Research, Lymphomas, Non-Hodgkin lymphoma, Drug development, Clinical Research, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Real-world evidence, Aggressive lymphoma, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Study Population, Human
Saturday, December 7, 2024: 9:30 AM-11:00 AM
Pacific Ballroom Salons 18-19
(Marriott Marquis San Diego Marina)
Moderators:
Elise A. Chong, MD, ARRAY(0xf8c35ec)
and
Andrew P Jallouk, MD, PhD, Vanderbilt University Medical Center
Disclosures:
Chong: AbbVie: Consultancy, Research Funding; Genentech/Roche: Research Funding; CARGO: Research Funding; Nurix: Research Funding; AstraZeneca: Consultancy, Research Funding; Beigene: Consultancy; Genmab: Consultancy, Research Funding. Jallouk: Kite/Gilead: Consultancy, Research Funding; Allogene Therapeutics: Research Funding.
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH